嵌合抗原受体
抗原
多发性骨髓瘤
受体
免疫学
医学
癌症研究
生物
T细胞
内科学
免疫系统
作者
Michael Rade,Nora Grieb,R. Weiß,Junren Sia,Luise Fischer,Patrick Born,Andreas Boldt,Stephan Fricke,Paul Franz,Jonathan Scolnick,Lakshmi Venkatraman,Stacy Xu,Christina Kloetzer,Simone Heyn,Anne Sophie Kubasch,Ronny Baber,Song‐Yau Wang,Enrica Bach,Sandra Hoffmann,Jule Ussmann
出处
期刊:Nature cancer
[Nature Portfolio]
日期:2024-04-19
卷期号:5 (9): 1318-1333
被引量:13
标识
DOI:10.1038/s43018-024-00763-8
摘要
Markers that predict response and resistance to chimeric antigen receptor (CAR) T cells in relapsed/refractory multiple myeloma are currently missing. We subjected mononuclear cells isolated from peripheral blood and bone marrow before and after the application of approved B cell maturation antigen-directed CAR T cells to single-cell multiomic analyses to identify markers associated with resistance and early relapse. Differences between responders and nonresponders were identified at the time of leukapheresis. Nonresponders showed an immunosuppressive microenvironment characterized by increased numbers of monocytes expressing the immune checkpoint molecule CD39 and suppressed CD8
科研通智能强力驱动
Strongly Powered by AbleSci AI